UNTY
NASDAQ · Banking
Unity Bancorp Inc
$51.02
+0.31 (+0.61%)
UNTY News5 articles
ImmunityBio Surges on NK-Cell Manufacturing Milestone, Anktiva Expansion Progress
ImmunityBio shares jumped 10.5% Friday following news of a completed scalable manufacturing process for its NK-cell therapy platform and regulatory progress for its drug Anktiva. The company also reported surging 2025 revenue.
ImmunityBio Shares Dip Ahead of Key Business Update Call
ImmunityBio shares edged lower in premarket activity Tuesday, giving back some of the prior session's gains ahead of a scheduled business update and full-year results call later in the day.
Unity Software Plunges on Weak Q1 Forecast, AI Concerns
Unity Software shares dropped nearly 10% following a weak first-quarter revenue forecast and analyst warnings about competitive threats from artificial intelligence.
Unity Stock Stabilizes After Sharp Guidance Cut, AI Concerns Loom
Unity shares held near $21.41 in premarket trading following a 26% plunge after the company issued weaker-than-expected Q1 revenue guidance. Investors are monitoring demand for its Create tools and advertising segment.
ImmunityBio Shares Stabilize After 15% Surge, Focus Turns to Upcoming Earnings
ImmunityBio's stock held steady near $7 in premarket trading following a sharp 14.6% rally. Investors are now awaiting the company's quarterly results, due in early March.